New-onset diabetes as an emerging risk group for early detection of pancreatic cancer: current evidence, clinical challenge, and future directions.
Saved in:
| Title: | New-onset diabetes as an emerging risk group for early detection of pancreatic cancer: current evidence, clinical challenge, and future directions. |
|---|---|
| Authors: | Tao, Lan Valerie1,2,3 (AUTHOR), Karasinska, Joanna M.1,3 (AUTHOR), Souza, Vanessa G. P.1 (AUTHOR), Loree, Jonathan M.3,4 (AUTHOR), Johnson, James D.5 (AUTHOR), Renouf, Daniel J.3,4 (AUTHOR), Schaeffer, David F.3,6,7 (AUTHOR) david.schaeffer@vch.ca |
| Source: | Frontiers in Gastroenterology (Frontiers Media S.A.). 2026, p1-15. 15p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 28131169 |
|---|---|
| DOI: | 10.3389/fgstr.2025.1645459 |
